MENU
+Compare
SPRO
Stock ticker: NASDAQ
AS OF
Dec 18, 04:56 PM (EDT)
Price
$1.00
Change
-$0.03 (-2.91%)
Capitalization
56.43M

SPRO Spero Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for SPRO with price predictions
Dec 17, 2024

SPRO sees MACD Histogram just turned negative

SPRO saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 12, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRO as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SPRO moved below its 50-day moving average on November 14, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SPRO crossed bearishly below the 50-day moving average on November 18, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SPRO entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRO advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

SPRO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.861) is normal, around the industry mean (14.664). P/E Ratio (12.938) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). SPRO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.621) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SPRO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SPRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SPRO is expected to report earnings to rise 12.50% to -36 cents per share on March 13

Spero Therapeutics SPRO Stock Earnings Reports
Q4'24
Est.
$-0.36
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.05
Q1'24
Missed
by $0.12
Q4'23
Beat
by $1.02
The last earnings report on November 14 showed earnings per share of -31 cents, beating the estimate of -50 cents. With 308.43K shares outstanding, the current market capitalization sits at 56.43M.
A.I. Advisor
published General Information

General Information

a developer of novel therapies for the treatment of resistant bacterial infections

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMRX1.73N/A
N/A
Immuneering Corp
ICE152.79-1.79
-1.16%
Intercontinental Exchange
NTCT22.37-0.32
-1.41%
NetScout Systems
PB78.42-1.57
-1.96%
Prosperity Bancshares
LOCO12.41-0.40
-3.12%
El Pollo Loco Holdings

SPRO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRO has been loosely correlated with LXRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRO jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRO
1D Price
Change %
SPRO100%
-3.27%
LXRX - SPRO
37%
Loosely correlated
-4.64%
DNLI - SPRO
35%
Loosely correlated
-0.30%
BEAM - SPRO
34%
Loosely correlated
-1.21%
ABOS - SPRO
33%
Loosely correlated
-0.51%
XNCR - SPRO
33%
Poorly correlated
+2.12%
More